Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

Weighting the impact of virulence on the outcome of Pseudomonas aeruginosa bloodstream infections.

Sánchez-Diener I, Zamorano L, Peña C, Ocampo-Sosa A, Cabot G, Gómez-Zorrilla S, Almirante B, Aguilar M, Granados A, Calbo E, Baño JR, Rodríguez-López F, Tubau F, Martínez-Martínez L, Navas A, Oliver A.

Clin Microbiol Infect. 2019 Jul 6. pii: S1198-743X(19)30389-1. doi: 10.1016/j.cmi.2019.06.034. [Epub ahead of print]

PMID:
31288102
2.

High delayed mortality after the first episode of Clostridium difficile infection.

Cózar A, Ramos-Martínez A, Merino E, Martínez-García C, Shaw E, Marrodán T, Calbo E, Bereciartúa E, Sánchez-Muñoz LA, Salavert M, Pérez-Rodríguez MT, García D, Bravo-Ferrer JM, Gálvez-Acebal J, Henríquez C, Cuquet J, Gil-Campesino H, Torres L, Sánchez-Porto A, Royuela A, Cobo J; Study group.

Anaerobe. 2019 Jun;57:93-98. doi: 10.1016/j.anaerobe.2019.04.004. Epub 2019 Apr 5.

PMID:
30959165
3.

Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study.

Bartoletti M, Giannella M, Lewis RE, Caraceni P, Tedeschi S, Paul M, Schramm C, Bruns T, Merli M, Cobos-Trigueros N, Seminari E, Retamar P, Muñoz P, Tumbarello M, Burra P, Cerenzia MT, Barsic B, Calbo E, Maraolo AE, Petrosillo N, Galan-Ladero MA, D'Offizi G, Zak-Doron Y, Rodriguez-Baño J, Baldassarre M, Verucchi G, Domenicali M, Bernardi M, Viale P; ESGBIS/BICHROME study group.

Clin Infect Dis. 2019 Jan 14. doi: 10.1093/cid/ciz032. [Epub ahead of print]

PMID:
30649218
4.

Assessment of Quality Indicators for Appropriate Antibiotic Use.

Arcenillas P, Boix-Palop L, Gómez L, Xercavins M, March P, Martinez L, Riera M, Madridejos R, Badia C, Nicolás J, Calbo E.

Antimicrob Agents Chemother. 2018 Nov 26;62(12). pii: e00875-18. doi: 10.1128/AAC.00875-18. Print 2018 Dec.

5.

Top-ten papers in Infection Control (2015-2017).

Dietl B, Calbo E.

Rev Esp Quimioter. 2018 Sep;31 Suppl 1:62-65. Review.

6.

Predictors of outcome in patients with severe sepsis or septic shock due to extended-spectrum β-lactamase-producing Enterobacteriaceae.

Russo A, Falcone M, Gutiérrez-Gutiérrez B, Calbo E, Almirante B, Viale PL, Oliver A, Ruiz-Garbajosa P, Gasch O, Gozalo M, Pitout J, Akova M, Peña C, Cisneros JM, Hernández-Torres A, Farcomeni A, Prim N, Origüen J, Bou G, Tacconelli E, Tumbarello M, Hamprecht A, Karaiskos I, de la Calle C, Pérez F, Schwaber MJ, Bermejo J, Lowman W, Hsueh PR, Mora-Rillo M, Rodriguez-Gomez J, Souli M, Bonomo RA, Paterson DL, Carmeli Y, Pascual A, Rodríguez-Baño J, Venditti M; REIPI/ESGBIS/INCREMENT investigators.

Int J Antimicrob Agents. 2018 Nov;52(5):577-585. doi: 10.1016/j.ijantimicag.2018.06.018. Epub 2018 Jun 30.

PMID:
29969692
7.

Comparison of Predictors and Mortality Between Bloodstream Infections Caused by ESBL-Producing Escherichia coli and ESBL-Producing Klebsiella pneumoniae.

Scheuerman O, Schechner V, Carmeli Y, Gutiérrez-Gutiérrez B, Calbo E, Almirante B, Viale PL, Oliver A, Ruiz-Garbajosa P, Gasch O, Gozalo M, Pitout J, Akova M, Peña C, Molina J, Hernández-Torres A, Venditti M, Prim N, Origüen J, Bou G, Tacconelli E, Tumbarello M, Hamprecht A, Karaiskos I, de la Calle C, Pérez F, Schwaber MJ, Bermejo J, Lowman W, Hsueh PR, Navarro-San Francisco C, Bonomo RA, Paterson DL, Pascual A, Rodríguez-Baño J; REIPI/ESGBIS/INCREMENT investigators.

Infect Control Hosp Epidemiol. 2018 Jun;39(6):660-667. doi: 10.1017/ice.2018.63. Epub 2018 Apr 5.

PMID:
29618394
8.

Genetic susceptibility to invasive pneumococcal disease.

Sangil A, Arranz MJ, Güerri-Fernández R, Pérez M, Monzón H, Payeras A, Andrés M, Torviso J, Ibañez L, Garau J, Calbo E.

Infect Genet Evol. 2018 Apr;59:126-131. doi: 10.1016/j.meegid.2018.01.024. Epub 2018 Jan 31.

PMID:
29407193
9.

Ceftolozane/tazobactam in the treatment of osteomyelitis and skin and soft-tissue infections due to extensively drug-resistant Pseudomonas aeruginosa: clinical and microbiological outcomes.

Dietl B, Sánchez I, Arcenillas P, Cuchi E, Gómez L, González de Molina FJ, Boix-Palop L, Nicolás J, Calbo E.

Int J Antimicrob Agents. 2018 Mar;51(3):498-502. doi: 10.1016/j.ijantimicag.2017.11.003. Epub 2017 Nov 20.

PMID:
29158144
10.

Empiric Therapy With Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Results From the INCREMENT Cohort.

Palacios-Baena ZR, Gutiérrez-Gutiérrez B, Calbo E, Almirante B, Viale P, Oliver A, Pintado V, Gasch O, Martínez-Martínez L, Pitout J, Akova M, Peña C, Molina Gil-Bermejo J, Hernández A, Venditti M, Prim N, Bou G, Tacconelli E, Tumbarello M, Hamprecht A, Giamarellou H, Almela M, Pérez F, Schwaber MJ, Bermejo J, Lowman W, Hsueh PR, Paño-Pardo JR, Torre-Cisneros J, Souli M, Bonomo RA, Carmeli Y, Paterson DL, Pascual Á, Rodríguez-Baño J; Spanish Network for Research in Infectious Diseases (REIPI)/European Study Group of Bloodstream Infections and Sepsis (ESGBIS)/INCREMENT Group.

Clin Infect Dis. 2017 Oct 30;65(10):1615-1623. doi: 10.1093/cid/cix606.

11.

Prediction of recurrent clostridium difficile infection at the bedside: the GEIH-CDI score.

Cobo J, Merino E, Martínez C, Cózar-Llistó A, Shaw E, Marrodán T, Calbo E, Bereciartúa E, Sánchez-Muñoz LA, Salavert M, Pérez-Rodríguez MT, García-Rosado D, Bravo-Ferrer JM, Gálvez-Acebal J, Henríquez-Camacho C, Cuquet J, Pino-Calm B, Torres L, Sánchez-Porto A, Fernández-Félix BM; Nosocomial Infection Study Group.

Int J Antimicrob Agents. 2018 Mar;51(3):393-398. doi: 10.1016/j.ijantimicag.2017.09.010. Epub 2017 Sep 20.

PMID:
28939450
12.

A prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients.

Bartoletti M, Giannella M, Lewis R, Caraceni P, Tedeschi S, Paul M, Schramm C, Bruns T, Merli M, Cobos-Trigueros N, Seminari E, Retamar P, Muñoz P, Tumbarello M, Burra P, Torrani Cerenzia M, Barsic B, Calbo E, Maraolo AE, Petrosillo N, Galan-Ladero MA, D'Offizi G, Bar Sinai N, Rodríguez-Baño J, Verucchi G, Bernardi M, Viale P; ESGBIS/BICHROME Study Group.

Clin Microbiol Infect. 2018 May;24(5):546.e1-546.e8. doi: 10.1016/j.cmi.2017.08.001. Epub 2017 Aug 14.

13.

Geographical variation in therapy for bloodstream infections due to multidrug-resistant Enterobacteriaceae: a post-hoc analysis of the INCREMENT study.

Harris PNA, Pezzani MD, Gutiérrez-Gutiérrez B, Viale P, Hsueh PR, Ruiz-Garbajosa P, Venditti M, Tumbarello M, Navarro-Francisco C, Calbo E, Akova M, Giamarellou H, Oliver A, Almirante B, Gasch O, Martínez-Martínez L, Schwaber MJ, Daikos G, Pitout J, Peña C, Hernández-Torres A, Doi Y, Pérez F, Tuon FF, Tacconelli E, Carmeli Y, Bonomo RA, Pascual Á, Paterson DL, Rodríguez-Baño J; ESGBIS/REIPI/INCREMENT Group.

Int J Antimicrob Agents. 2017 Nov;50(5):664-672. doi: 10.1016/j.ijantimicag.2017.08.005. Epub 2017 Aug 3.

PMID:
28782704
14.

Emerging extended-spectrum β-lactamase-producing Klebsiella pneumoniae causing community-onset urinary tract infections: a case-control-control study.

Boix-Palop L, Xercavins M, Badía C, Obradors M, Riera M, Freixas N, Pérez J, Rodríguez-Carballeira M, Garau J, Calbo E.

Int J Antimicrob Agents. 2017 Aug;50(2):197-202. doi: 10.1016/j.ijantimicag.2017.03.009. Epub 2017 May 24.

PMID:
28552471
15.

Development and validation of the INCREMENT-ESBL predictive score for mortality in patients with bloodstream infections due to extended-spectrum-β-lactamase-producing Enterobacteriaceae.

Palacios-Baena ZR, Gutiérrez-Gutiérrez B, De Cueto M, Viale P, Venditti M, Hernández-Torres A, Oliver A, Martínez-Martínez L, Calbo E, Pintado V, Gasch O, Almirante B, Antonio Lepe J, Pitout J, Akova M, Peña-Miralles C, Schwaber MJ, Tumbarello M, Tacconelli E, Origüen J, Prim N, Bou G, Giamarellou H, Bermejo J, Hamprecht A, Pérez F, Almela M, Lowman W, Hsueh PR, Navarro-San Francisco C, Torre-Cisneros J, Carmeli Y, Bonomo RA, Paterson DL, Pascual Á, Rodríguez-Baño J; REIPI/ESGBIS/INCREMENT Group.

J Antimicrob Chemother. 2017 Mar 1;72(3):906-913. doi: 10.1093/jac/dkw513.

16.

Bacillus species pseudo-outbreak: construction works and collateral damage.

Boix-Palop L, Nicolás C, Xercavins M, Riera M, Prim N, Freixas N, Pérez J, Calbo E.

J Hosp Infect. 2017 Jan;95(1):118-122. doi: 10.1016/j.jhin.2016.10.013. Epub 2016 Oct 24.

PMID:
27856013
17.

Bloodstream infections caused by Escherichia coli producing AmpC β-lactamases: epidemiology and clinical features.

Pascual V, Alonso N, Simó M, Ortiz G, Garcia MC, Xercavins M, Rivera A, Morera MA, Miró E, Espejo E, Navarro F, Gurguí M, Pérez J, Rodríguez-Carballeira M, Garau J, Calbo E.

Eur J Clin Microbiol Infect Dis. 2016 Dec;35(12):1997-2003. Epub 2016 Aug 22.

PMID:
27549108
18.

A Multinational, Preregistered Cohort Study of β-Lactam/β-Lactamase Inhibitor Combinations for Treatment of Bloodstream Infections Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae.

Gutiérrez-Gutiérrez B, Pérez-Galera S, Salamanca E, de Cueto M, Calbo E, Almirante B, Viale P, Oliver A, Pintado V, Gasch O, Martínez-Martínez L, Pitout J, Akova M, Peña C, Molina J, Hernández A, Venditti M, Prim N, Origüen J, Bou G, Tacconelli E, Tumbarello M, Hamprecht A, Giamarellou H, Almela M, Pérez F, Schwaber MJ, Bermejo J, Lowman W, Hsueh PR, Mora-Rillo M, Natera C, Souli M, Bonomo RA, Carmeli Y, Paterson DL, Pascual A, Rodríguez-Baño J.

Antimicrob Agents Chemother. 2016 Jun 20;60(7):4159-69. doi: 10.1128/AAC.00365-16. Print 2016 Jul.

19.

Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: a multinational pre-registered cohort study.

Gutiérrez-Gutiérrez B, Bonomo RA, Carmeli Y, Paterson DL, Almirante B, Martínez-Martínez L, Oliver A, Calbo E, Peña C, Akova M, Pitout J, Origüen J, Pintado V, García-Vázquez E, Gasch O, Hamprecht A, Prim N, Tumbarello M, Bou G, Viale P, Tacconelli E, Almela M, Pérez F, Giamarellou H, Cisneros JM, Schwaber MJ, Venditti M, Lowman W, Bermejo J, Hsueh PR, Mora-Rillo M, Gracia-Ahulfinger I, Pascual A, Rodríguez-Baño J; REIPI/ESGBIS/INCREMENT Group.

J Antimicrob Chemother. 2016 Jun;71(6):1672-80. doi: 10.1093/jac/dkv502. Epub 2016 Feb 22.

20.

Molecular characterisation of acquired and overproduced chromosomal blaAmpC in Escherichia coli clinical isolates.

Alonso N, Miró E, Pascual V, Rivera A, Simó M, Garcia MC, Xercavins M, Morera MA, Espejo E, Gurguí M, Pérez J, Rodríguez-Carballeira M, Garau J, Calbo E, Navarro F, Mirelis B, Coll P.

Int J Antimicrob Agents. 2016 Jan;47(1):62-8. doi: 10.1016/j.ijantimicag.2015.10.007. Epub 2015 Nov 2.

PMID:
26607336
21.

Impact of vaccination on invasive pneumococcal disease in adults with focus on the immunosuppressed.

Sangil A, Xercavins M, Rodríguez-Carballeira M, Andrés M, Riera M, Espejo E, Pérez J, Garau J, Calbo E.

J Infect. 2015 Oct;71(4):422-7. doi: 10.1016/j.jinf.2015.07.004. Epub 2015 Jul 18.

PMID:
26192199
22.

Pseudomonas aeruginosa nosocomial pneumonia: impact of pneumonia classification.

Micek ST, Kollef MH, Torres A, Chen C, Rello J, Chastre J, Antonelli M, Welte T, Clair B, Ostermann H, Calbo E, Wunderink R, Menichetti F, Schramm G, Menon V.

Infect Control Hosp Epidemiol. 2015 Oct;36(10):1190-7. doi: 10.1017/ice.2015.167. Epub 2015 Jul 20.

PMID:
26190444
23.

The changing epidemiology of hospital outbreaks due to ESBL-producing Klebsiella pneumoniae: the CTX-M-15 type consolidation.

Calbo E, Garau J.

Future Microbiol. 2015;10(6):1063-75. doi: 10.2217/fmb.15.22. Review.

PMID:
26059626
24.

An international multicenter retrospective study of Pseudomonas aeruginosa nosocomial pneumonia: impact of multidrug resistance.

Micek ST, Wunderink RG, Kollef MH, Chen C, Rello J, Chastre J, Antonelli M, Welte T, Clair B, Ostermann H, Calbo E, Torres A, Menichetti F, Schramm GE, Menon V.

Crit Care. 2015 May 6;19:219. doi: 10.1186/s13054-015-0926-5.

25.

Daptomycin plus fosfomycin versus daptomycin monotherapy in treating MRSA: protocol of a multicentre, randomised, phase III trial.

Shaw E, Miró JM, Puig-Asensio M, Pigrau C, Barcenilla F, Murillas J, Garcia-Pardo G, Espejo E, Padilla B, Garcia-Reyne A, Pasquau J, Rodriguez-Baño J, López-Contreras J, Montero M, de la Calle C, Pintado V, Calbo E, Gasch O, Montejo M, Salavert M, Garcia-Pais MJ, Carratalà J, Pujol M; Spanish Network for Research in Infectious Diseases (REIPI RD12/0015); Instituto de Salud Carlos III, Madrid, Spain; GEIH (Hospital Infection Study Group).

BMJ Open. 2015 Mar 11;5(3):e006723. doi: 10.1136/bmjopen-2014-006723.

26.

Epidemiology and risk factors for infections due to AmpC β-lactamase-producing Escherichia coli.

Pascual V, Ortiz G, Simó M, Alonso N, Garcia MC, Xercavins M, Rivera A, Morera MA, Miró E, Espejo E, Navarro F, Gurguí M, Pérez J, Rodríguez-Carballeira M, Garau J, Calbo E.

J Antimicrob Chemother. 2015 Mar;70(3):899-904. doi: 10.1093/jac/dku468. Epub 2014 Dec 2.

PMID:
25468902
27.

Influence of virulence genotype and resistance profile in the mortality of Pseudomonas aeruginosa bloodstream infections.

Peña C, Cabot G, Gómez-Zorrilla S, Zamorano L, Ocampo-Sosa A, Murillas J, Almirante B, Pomar V, Aguilar M, Granados A, Calbo E, Rodríguez-Baño J, Rodríguez-López F, Tubau F, Martínez-Martínez L, Oliver A; Spanish Network for Research in Infectious Diseases (REIPI).

Clin Infect Dis. 2015 Feb 15;60(4):539-48. doi: 10.1093/cid/ciu866. Epub 2014 Nov 6.

PMID:
25378459
28.

Risk factors for severe sepsis in community-onset bacteraemic urinary tract infection: impact of antimicrobial resistance in a large hospitalised cohort.

Shaw E, Benito N, Rodríguez-Baño J, Padilla B, Pintado V, Calbo E, Pallarés MA, Gozalo M, Ruiz-Garbajosa P, Horcajada JP; REIPI/ITUBRAS-GEIH group, Spain.

J Infect. 2015 Mar;70(3):247-54. doi: 10.1016/j.jinf.2014.09.011. Epub 2014 Oct 12.

PMID:
25305497
29.

[The threat of the carbapenemase-producing enterobacteriaceae in Spain: positioning report of the SEIMC study groups, GEIH and GEMARA].

Oteo J, Calbo E, Rodríguez-Baño J, Oliver A, Hornero A, Ruiz-Garbajosa P, Horcajada JP, Del Pozo JL, Riera M, Sierra R, Bou G, Salavert M.

Enferm Infecc Microbiol Clin. 2014 Dec;32(10):666-70. doi: 10.1016/j.eimc.2014.02.011. Epub 2014 Apr 22. Spanish.

PMID:
24767691
30.

[Ceftaroline fosamil in community-acquired and nosocomial pneumonia].

Calbo E, Zaragoza R.

Enferm Infecc Microbiol Clin. 2014 Mar;32 Suppl 2:38-43. doi: 10.1016/S0213-005X(14)70157-0. Spanish.

PMID:
24702978
31.

A review of the factors influencing antimicrobial prescribing.

Calbo E, Alvarez-Rocha L, Gudiol F, Pasquau J.

Enferm Infecc Microbiol Clin. 2013 Sep;31 Suppl 4:12-5. doi: 10.1016/S0213-005X(13)70127-7.

PMID:
24129284
32.

Emergence of resistance to daptomycin in a cohort of patients with methicillin-resistant Staphylococcus aureus persistent bacteraemia treated with daptomycin.

Gasch O, Camoez M, Domínguez MA, Padilla B, Pintado V, Almirante B, Martín C, López-Medrano F, de Gopegui ER, Blanco JR, García-Pardo G, Calbo E, Montero M, Granados A, Jover A, Dueñas C, Pujol M; REIPI/GEIH study groups.

J Antimicrob Chemother. 2014 Feb;69(2):568-71. doi: 10.1093/jac/dkt396. Epub 2013 Oct 9. No abstract available.

PMID:
24107389
33.

Lack of association between genotypes and haematogenous seeding infections in a large cohort of patients with methicillin-resistant Staphylococcus aureus bacteraemia from 21 Spanish hospitals.

Gasch O, Camoez M, Dominguez MA, Padilla B, Pintado V, Almirante B, Martín-Gandul C, López-Medrano F, de Gopegui ER, Ramón Blanco J, García-Pardo G, Calbo E, Horcajada JP, Granados A, Jover-Sáenz A, Dueñas C, Pujol M; REIPI/GEIM Study Groups.

Clin Microbiol Infect. 2014 Apr;20(4):361-7. doi: 10.1111/1469-0691.12330. Epub 2013 Aug 28.

34.

Effect of adequate single-drug vs combination antimicrobial therapy on mortality in Pseudomonas aeruginosa bloodstream infections: a post Hoc analysis of a prospective cohort.

Peña C, Suarez C, Ocampo-Sosa A, Murillas J, Almirante B, Pomar V, Aguilar M, Granados A, Calbo E, Rodríguez-Baño J, Rodríguez F, Tubau F, Oliver A, Martínez-Martínez L; Spanish Network for Research in Infectious Diseases (REIPI).

Clin Infect Dis. 2013 Jul;57(2):208-16. doi: 10.1093/cid/cit223. Epub 2013 Apr 11.

PMID:
23580739
35.

Hand contamination during routine care in medical wards: the role of hand hygiene compliance.

Monistrol O, López ML, Riera M, Font R, Nicolás C, Escobar MA, Freixas N, Garau J, Calbo E.

J Med Microbiol. 2013 Apr;62(Pt 4):623-9. doi: 10.1099/jmm.0.050328-0. Epub 2013 Jan 17.

PMID:
23329322
36.

Healthcare-associated, community-acquired and hospital-acquired bacteraemic urinary tract infections in hospitalized patients: a prospective multicentre cohort study in the era of antimicrobial resistance.

Horcajada JP, Shaw E, Padilla B, Pintado V, Calbo E, Benito N, Gamallo R, Gozalo M, Rodríguez-Baño J; ITUBRAS group; Grupo de Estudio de Infección Hospitalaria (GEIH); Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC).

Clin Microbiol Infect. 2013 Oct;19(10):962-8. doi: 10.1111/1469-0691.12089. Epub 2012 Dec 22.

37.

Bilateral lung and liver hydatid cysts. Case report.

Geraci G, Sciuto A, Lo Nigro C, Sciumè C, Li Volsi F, Cupido F, Calbo E, Modica G.

G Chir. 2012 Jun-Jul;33(6-7):229-33.

PMID:
22958805
38.

Aetiology of community-acquired pneumonia among adults in an H1N1 pandemic year: the role of respiratory viruses.

Sangil A, Calbo E, Robles A, Benet S, Viladot ME, Pascual V, Cuchí E, Pérez J, Barreiro B, Sánchez B, Torres J, Canales L, De Marcos JA, Garau J.

Eur J Clin Microbiol Infect Dis. 2012 Oct;31(10):2765-72. Epub 2012 May 2.

PMID:
22549730
39.

A rare case of giant papillary adenoma of the breast.

Marullo M, Catalfamo A, Sciglitano P, Calbo E, Plutino F, Campisi G, Maniaci FV, Vecchio DA, Gorgone S, Calbo L.

G Chir. 2012 Mar;33(3):86-8.

PMID:
22525553
40.

Parathyroid carcinoma presenting as normocalcemic hyperparathyroidism.

Campennì A, Ruggeri RM, Sindoni A, Giovinazzo S, Calbo E, Ieni A, Calbo L, Tuccari G, Baldari S, Benvenga S.

J Bone Miner Metab. 2012 May;30(3):367-72. doi: 10.1007/s00774-011-0344-y. Epub 2012 Jan 14.

PMID:
22246083
41.

Impact of a hand hygiene educational programme on hospital-acquired infections in medical wards.

Monistrol O, Calbo E, Riera M, Nicolás C, Font R, Freixas N, Garau J.

Clin Microbiol Infect. 2012 Dec;18(12):1212-8. doi: 10.1111/j.1469-0691.2011.03735.x. Epub 2011 Dec 22.

42.

[Programs for optimizing the use of antibiotics (PROA) in Spanish hospitals: GEIH-SEIMC, SEFH and SEMPSPH consensus document].

Rodríguez-Baño J, Paño-Pardo JR, Alvarez-Rocha L, Asensio A, Calbo E, Cercenado E, Cisneros JM, Cobo J, Delgado O, Garnacho-Montero J, Grau S, Horcajada JP, Hornero A, Murillas-Angoiti J, Oliver A, Padilla B, Pasquau J, Pujol M, Ruiz-Garbajosa P, San Juan R, Sierra R; Grupo de Estudio de la Infección Hospitalaria-Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica; Sociedad Española de Farmacia Hospitalaria; Sociedad Española de Medicina Preventiva, Salud Pública e Higiene.

Enferm Infecc Microbiol Clin. 2012 Jan;30(1):22.e1-22.e23. doi: 10.1016/j.eimc.2011.09.018. Epub 2011 Dec 15. Spanish.

PMID:
22178010
43.

Prospective multicenter study of the impact of carbapenem resistance on mortality in Pseudomonas aeruginosa bloodstream infections.

Peña C, Suarez C, Gozalo M, Murillas J, Almirante B, Pomar V, Aguilar M, Granados A, Calbo E, Rodríguez-Baño J, Rodríguez F, Tubau F, Martínez-Martínez L, Oliver A; Spanish Network for Research in Infectious Diseases REIPI.

Antimicrob Agents Chemother. 2012 Mar;56(3):1265-72. doi: 10.1128/AAC.05991-11. Epub 2011 Dec 12.

44.

[Programs for optimizing the use of antibiotics (PROA) in Spanish hospitals: GEIH-SEIMC, SEFH and SEMPSPH consensus document].

Rodríguez-Baño J, Paño-Pardo JR, Alvarez-Rocha L, Asensio Á, Calbo E, Cercenado E, Cisneros JM, Cobo J, Delgado O, Garnacho-Montero J, Grau S, Horcajada JP, Hornero A, Murillas-Angoiti J, Oliver A, Padilla B, Pasquau J, Pujol M, Ruiz-Garbajosa P, San Juan R, Sierra R; GEIH-SEIMC; SEFH; SEMPSPH.

Farm Hosp. 2012 Jan-Feb;36(1):33.e1-30. doi: 10.1016/j.farma.2011.10.001. Epub 2011 Dec 1. Spanish.

PMID:
22137161
45.

Meningocele due to closed spina bifida mimicking a metastasis of papillary thyroid carcinoma on whole body radioactive iodine scan.

Baldari S, Sturniolo G, Violi MA, Moleti M, Campennì A, Calbo E, Presti S, Blandino A, Trimarchi F, Vermiglio F.

Thyroid. 2011 Dec;21(12):1401-2. doi: 10.1089/thy.2011.0212. Epub 2011 Nov 8. No abstract available.

PMID:
22066481
46.

H1N1 influenza pneumonia and bacterial coinfection.

Calbo E, Robles A, Sangil A, Benet S, Viladot ME, Pascual V, Barreiro B.

Thorax. 2011 Dec;66(12):1091-2; author reply 1091. doi: 10.1136/thoraxjnl-2011-200410. Epub 2011 Oct 12.

PMID:
21994246
47.

Factors affecting the development of systemic inflammatory response syndrome in pneumococcal infections.

Calbo E, Garau J.

Curr Opin Infect Dis. 2011 Jun;24(3):241-7. doi: 10.1097/QCO.0b013e3283463e45. Review.

PMID:
21522066
48.

Foodborne nosocomial outbreak of SHV1 and CTX-M-15-producing Klebsiella pneumoniae: epidemiology and control.

Calbo E, Freixas N, Xercavins M, Riera M, Nicolás C, Monistrol O, Solé Mdel M, Sala MR, Vila J, Garau J.

Clin Infect Dis. 2011 Mar 15;52(6):743-9. doi: 10.1093/cid/ciq238.

PMID:
21367727
49.

[Adrenal incidentaloma in elderly patients].

Calbo L, Catalfamo A, Sciglitano P, Calbo E, Plutino F, Campisi G, Didio V, Gorgone S.

G Chir. 2010 Aug-Sep;31(8-9):409-12. Review. Italian.

PMID:
20843449
50.

Procalcitonin levels are lower in intensive care unit patients with H1N1 influenza A virus pneumonia than in those with community-acquired bacterial pneumonia. A pilot study.

Piacentini E, Sánchez B, Arauzo V, Calbo E, Cuchi E, Nava JM.

J Crit Care. 2011 Apr;26(2):201-5. doi: 10.1016/j.jcrc.2010.07.009. Epub 2010 Sep 1.

PMID:
20813489

Supplemental Content

Support Center